BackPraxis Precision Medicines Overview
Praxis Precision Medicines Inc

Praxis Precision Medicines Target Price

Analysts' average 12-month price target for Praxis Precision Medicines is $560.

Get informed when a big investor buys or sells

+ Follow

Share Price

$368.46

Average Target Price

$555.8350.9% upside

18 analysts in the last 4 months

High: $1245 | Low: $162

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-07RBC CapitalLeonid Timashev$46225.4% upsideOpen
2026-08-07Robert W. Baird$51439.5% upsideOpen
2026-08-07Wells FargoBenjamin Burnett$3621.8% downsideOpen
2026-07-13Goldman Sachs$44721.3% upsideOpen
2026-06-29NeedhamAmi Fadia$57556.1% upsideOpen
2026-06-17RBC CapitalLeonid Timashev$44921.9% upsideOpen
2026-06-02Truist Financial$61667.2% upsideOpen
2026-06-02Wedbush$16256% downsideOpen
2026-06-02OppenheimerJay Olson$65076.4% upsideOpen
2026-06-02Robert W. Baird$4008.6% upsideOpen
2026-06-02H.C. Wainwright$1,201226% upsideOpen
2026-06-02BTIGKambiz Yazdi$810119.8% upsideOpen
2026-06-02Deutsche BankDavid Hoang$3741.5% upsideOpen
2026-05-26H.C. WainwrightDouglas Tsao$1,245237.9% upsideOpen
2026-05-13Truist Financial$71594.1% upsideOpen
2026-05-08Wedbush$16654.9% downsideOpen
2026-05-08Deutsche Bank$42014% upsideOpen
2026-04-15Deutsche Bank$43718.6% upsideOpen
2026-04-10Raymond James$815121.2% upsideOpen
2026-02-23Wolfe Research$50035.7% upsideOpen
2026-02-20Truist Financial$70090% upsideOpen
2026-02-20Deutsche Bank$41211.8% upsideOpen
2026-02-20Robert W. Baird$43317.5% upsideOpen
2026-02-20Wells Fargo$30517.2% downsideOpen
2026-02-10Guggenheim$800117.1% upsideOpen
2026-02-04Needham$51038.4% upsideOpen
2026-02-02Wells Fargo$28223.5% downsideOpen
2026-01-05NeedhamAmi Fadia$46024.8% upsideOpen
2025-12-29BTIG$843128.8% upsideOpen
2025-12-15UBS$750103.5% upsideOpen
2025-12-15OppenheimerJay Olson$750103.5% upsideOpen
2025-12-12Deutsche Bank$31315.1% downsideOpen
2025-12-09Jefferies$45022.1% upsideOpen
2025-12-09GuggenheimYatin Suneja$760106.3% upsideOpen
2025-12-08Truist Financial$50035.7% upsideOpen
2025-12-08Needham$31514.5% downsideOpen
2025-12-08BTIGKambiz Yazdi$50737.6% upsideOpen
2025-12-05Deutsche Bank$30317.8% downsideOpen
2025-12-05Wedbush$8377.5% downsideOpen
2025-12-05Piper SandlerYasmeen Rahimi$45022.1% upsideOpen
2025-12-05BTIG$49935.4% upsideOpen
2025-12-05NeedhamAmi Fadia$30417.5% downsideOpen
2025-12-05H.C. Wainwright$3407.7% downsideOpen
2025-11-18BTIG$42415.1% upsideOpen
2025-11-06GuggenheimYatin Suneja$54046.6% upsideOpen
2025-10-17Deutsche Bank$28024% downsideOpen
2025-10-17Chardan Capital$33010.4% downsideOpen
2025-10-16JefferiesAndrew Tsai$30018.6% downsideOpen
2025-10-16Guggenheim$3505% downsideOpen
2025-08-05H.C. Wainwright$11568.8% downsideOpen

Praxis Precision Medicines (PRAX) FAQ

The latest target price for PRAX is $560. Investors often review this figure alongside Praxis Precision Medicines's historical trend and sector peers before judging valuation or financial health.

Praxis Precision Medicines trades near $368.46 while the consensus target sits at $560 (50.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting PRAX's target price ($560), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Praxis Precision Medicines's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.